UMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.
Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Am J Hum Genet. 2022 Oct 6;109(10):1909-1922. doi: 10.1016/j.ajhg.2022.08.008. Epub 2022 Aug 30.
The transmembrane protein TMEM147 has a dual function: first at the nuclear envelope, where it anchors lamin B receptor (LBR) to the inner membrane, and second at the endoplasmic reticulum (ER), where it facilitates the translation of nascent polypeptides within the ribosome-bound TMCO1 translocon complex. Through international data sharing, we identified 23 individuals from 15 unrelated families with bi-allelic TMEM147 loss-of-function variants, including splice-site, nonsense, frameshift, and missense variants. These affected children displayed congruent clinical features including coarse facies, developmental delay, intellectual disability, and behavioral problems. In silico structural analyses predicted disruptive consequences of the identified amino acid substitutions on translocon complex assembly and/or function, and in vitro analyses documented accelerated protein degradation via the autophagy-lysosomal-mediated pathway. Furthermore, TMEM147-deficient cells showed CKAP4 (CLIMP-63) and RTN4 (NOGO) upregulation with a concomitant reorientation of the ER, which was also witnessed in primary fibroblast cell culture. LBR mislocalization and nuclear segmentation was observed in primary fibroblast cells. Abnormal nuclear segmentation and chromatin compaction were also observed in approximately 20% of neutrophils, indicating the presence of a pseudo-Pelger-Huët anomaly. Finally, co-expression analysis revealed significant correlation with neurodevelopmental genes in the brain, further supporting a role of TMEM147 in neurodevelopment. Our findings provide clinical, genetic, and functional evidence that bi-allelic loss-of-function variants in TMEM147 cause syndromic intellectual disability due to ER-translocon and nuclear organization dysfunction.
跨膜蛋白 TMEM147 具有双重功能:首先在核膜上,它将核膜层蛋白 B 受体(LBR)锚定在内膜上;其次在内质网上,它促进核糖体结合的 TMCO1 易位通道复合物内新生多肽的翻译。通过国际数据共享,我们在 15 个无关联的家庭中发现了 23 名具有双等位 TMEM147 功能丧失变异的个体,包括剪接位点、无义、移码和错义变异。这些受影响的儿童表现出一致的临床特征,包括面容粗糙、发育迟缓、智力残疾和行为问题。计算机结构分析预测,鉴定的氨基酸取代对易位通道复合物组装和/或功能具有破坏性影响,体外分析记录了通过自噬溶酶体介导的途径加速蛋白质降解。此外,TMEM147 缺陷细胞显示 CKAP4(CLIMP-63)和 RTN4(NOGO)上调,同时内质网重新定向,这也在原代成纤维细胞培养中观察到。在原代成纤维细胞中观察到 LBR 定位错误和核分段。在大约 20%的中性粒细胞中也观察到异常核分段和染色质紧缩,表明存在假 Pelger-Huët 异常。最后,共表达分析显示与大脑中的神经发育基因存在显著相关性,进一步支持 TMEM147 在神经发育中的作用。我们的发现提供了临床、遗传和功能证据,表明 TMEM147 的双等位基因功能丧失变异导致 ER 易位通道和核组织功能障碍引起综合征性智力残疾。